Know Cancer

or
forgot password

Second Malignant Neoplasms After Childhood ALL Therapy; An International Ponte di Legno Study


N/A
N/A
20 Years
Not Enrolling
Both
Acute Lymphoblastic Leukemia

Thank you

Trial Information

Second Malignant Neoplasms After Childhood ALL Therapy; An International Ponte di Legno Study


To explore epidemiology, potential risk factors and survival rates of second cancers
occurring as the first event in childhood acute lymphoblastic leukemia the involved study
groups will collect anonymous data on all such cases diagnosed within the last decades to
form a common database with predefined variables comprising the clinical, biological, and
cytogenetic characteristics (myeloid neoplasias only) as well as outcome. Furthermore, we
will register the clinical, biological, and cytogenetic characteristics of the acute
lymphoblastic leukemia as well as type of treatment given.


Inclusion Criteria:



- Diagnosed with childhood acute lymphoblastic leukemia

- Diagnosis of second cancer before December 31st 2007

Exclusion Criteria:

- Uncertainty if the second cancer has emerged from the same original leukemic clone

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Retrospective

Outcome Measure:

Pattern of SMN subtypes

Outcome Description:

Pattern of the main groups of SMN and their clinical charactiristics

Outcome Time Frame:

At 20 years from diagnosis

Safety Issue:

No

Principal Investigator

Kjeld Schmiegelow, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Rigshospitalet, Denmark

Authority:

Denmark: Danish Dataprotection Agency

Study ID:

PdL SMN Study 1

NCT ID:

NCT01476462

Start Date:

January 2009

Completion Date:

December 2011

Related Keywords:

  • Acute Lymphoblastic Leukemia
  • Acute lymphoblastic leukemia
  • Ponte-di-Legno consortium
  • Second cancer
  • Survival
  • Neoplasms
  • Leukemia
  • Leukemia, Lymphoid
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma

Name

Location